Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Fatica

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Transplantation|September 24, 2013
CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|November 3, 2010
The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantationStuart M Flechner, Richard Fatica, Medhat Askar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2013
The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|March 14, 2007
Donor factors influencing graft outcomes in live donor kidney transplantationNaim Issa, Brian Stephany, Richard Fatica, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 22, 2012
The association of community health indicators with outcomes for kidney transplant recipients in the United StatesJesse D Schold, Laura D Buccini, Michael W Kattan, et al.
Clinical Transplantation|April 5, 2013
Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapyJennifer Cuellar-Rodriguez, Brian Stephany, Emilio Poggio, et al.
Clinical Transplantation|October 28, 2020
Continuous function of 80 primary renal allografts for 30-47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long-term successesWilliam E Braun, Leal Herlitz, Jianbo Li, et al.
Transplantation|August 5, 2010
Utility of leflunomide in the treatment of complex cytomegalovirus syndromesRobin K Avery, Sherif B Mossad, Emilio Poggio, et al.
Kidney International|December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKatharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.
Kidney Medicine|January 30, 2023
Renal Genetics Clinic: 3-Year Experience in the Cleveland ClinicXin Yee Tan, Chloe Borden, Mary-Beth Roberts, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Transplantation|September 24, 2013
CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|November 3, 2010
The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantationStuart M Flechner, Richard Fatica, Medhat Askar, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2013
The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantationNissreen Elfadawy, Stuart M Flechner, Xiaobo Liu, et al.
Transplantation|March 14, 2007
Donor factors influencing graft outcomes in live donor kidney transplantationNaim Issa, Brian Stephany, Richard Fatica, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 22, 2012
The association of community health indicators with outcomes for kidney transplant recipients in the United StatesJesse D Schold, Laura D Buccini, Michael W Kattan, et al.
Clinical Transplantation|April 5, 2013
Contrasting patterns of viral load response in transplant recipients with BK polyomavirus DNAemia on leflunomide therapyJennifer Cuellar-Rodriguez, Brian Stephany, Emilio Poggio, et al.
Clinical Transplantation|October 28, 2020
Continuous function of 80 primary renal allografts for 30-47 years with maintenance prednisone and azathioprine/mycophenolate mofetil therapy: A clinical mosaic of long-term successesWilliam E Braun, Leal Herlitz, Jianbo Li, et al.
Transplantation|August 5, 2010
Utility of leflunomide in the treatment of complex cytomegalovirus syndromesRobin K Avery, Sherif B Mossad, Emilio Poggio, et al.
Kidney International|December 26, 2019
Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKatharina Hopp, Emilie Cornec-Le Gall, Sarah R Senum, et al.
Kidney Medicine|January 30, 2023
Renal Genetics Clinic: 3-Year Experience in the Cleveland ClinicXin Yee Tan, Chloe Borden, Mary-Beth Roberts, et al.
Pageof 3